Pylarify - cleveland VAMC
Ended Awarded Last action
- Contract number
- 36C25025F0351
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $2,273,459
Award facts
- Contract value 100% obligated
- $2,273,458.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Additional Work (new agreement, FAR part 6 applies) | $4,835 | |
| Supplemental Agreement for work within scope | $24,000 | |
| Original award | $1,948,709 |
About this award
Veterans Integrated Service Network 10 issued a $2.27 million delivery order to Progenics Pharmaceuticals Inc. on March 1, 2025, for supply of PYLARIFY radiopharmaceuticals to Cleveland VAMC, with final delivery due February 28, 2026.
The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA-administered master vehicle supporting ongoing federal procurement of diagnostic imaging agents and radiopharmaceuticals. Place of performance is North Billerica, MA. Progenics Pharmaceuticals operates as a division of Lantheus Medical Imaging, Inc., a specialized supplier of nuclear medicine products and diagnostic imaging agents to federal healthcare providers. PYLARIFY (piflufolastat F-18) is a radioactive diagnostic agent used in positron emission tomography scans for prostate cancer detection and localization. The order carries firm fixed-price pricing with no set-aside designation.
Quick answers
Who was awarded contract 36C25025F0351?
36C25025F0351 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on March 1, 2025.
How much is contract 36C25025F0351 worth?
The government has obligated $2,273,459 on 36C25025F0351.
Is contract 36C25025F0351 an order under another contract?
Yes. 36C25025F0351 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25025F0351 competed?
The extent of competition for 36C25025F0351 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award